rs7895833 — SIRT1 A>G

SIRT1 Intronic Variant — Guardian of Cellular Stress Response

SIRT1 (Sirtuin 1) is a NAD-dependent deacetylase¹¹ NAD-dependent deacetylase
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme central to cellular energy metabolism with profound influence on aging, metabolism, neuroprotection, and mental health.

The sirtuin SIRT1 is expressed throughout the body, has broad biological effects and can significantly affect both cellular survival and longevity during acute and long-term injuries, which involve both oxidative stress and cell metabolism . This intronic A>G variant (rs7895833) sits in a regulatory region of the SIRT1 gene²² regulatory region of the SIRT1 gene
intronic variants can affect gene splicing, regulatory element binding, and ultimately protein expression levels and has been associated with expression levels of SIRT1 protein, particularly in aging populations.

The Mechanism

SIRT1 exerts a neuroprotective effect on various neurologic diseases through upregulation of SIRT1 which suppressed the expression levels of pro-inflammatory cytokines and increased the expression levels of superoxide dismutase 2 and catalase .

A significant increase in the SIRT1 level in older people was observed with a significant positive correlation between SIRT1 level and age, with the oldest people carrying AG genotypes for rs7895833 having the highest SIRT1 level suggesting an association between rs7895833 SNP and lifespan longevity . The G variant appears to modulate SIRT1 expression in a context-dependent manner — in some tissues and conditions increasing activity, in others potentially disrupting optimal function.

SIRT1 is a NAD+-dependent deacetylase that functions through nucleoplasmic transfer and is present in nearly all mammalian tissues, believed to deacetylate its protein substrates, resulting in neuroprotective actions, including reduced oxidative stress and inflammation, increased autophagy, increased nerve growth factors, and preserved neuronal integrity in aging or neurological disease .

The Evidence

The G allele frequency varies considerably by ancestry. A Brazilian geriatric study of 216 patients³³ A Brazilian geriatric study of 216 patients
Costa Ribeiro H et al. Polymorphism rs7895833 in the SIRT1 gene and its association with dyslipidaemia in the elderly. Rev Esp Geriatr Gerontol. 2019 found the G allele at 42% frequency and associated it with dyslipidemia. A 3-year Korean pediatric study⁴⁴ A 3-year Korean pediatric study
Lee M et al. The Gender Association of the SIRT1 rs7895833 Polymorphism with Pediatric Obesity: A 3-Year Panel Study. J Nutrigenet Nutrigenomics. 2016 of 219 children found GA+AA genotypes associated with higher BMI and obesity risk, particularly in boys who showed reduced cholesterol improvements compared to GG carriers.

rs7895833 was associated with increased odds of developing multiple sclerosis under co-dominant, overdominant, dominant, and allelic genetic models in a Lithuanian study of 250 MS patients. rs3818292 and rs7895833 were associated with an increased risk of developing exudative age-related macular degeneration, with rs7895833 associated with increased risk in women after strict Bonferroni correction .

Regarding mental health, mice with brain-specific Sirt1 knockout decreased anxiety and developed resilience to depression induced by social defeat, while mice with global Sirt1 overexpression had elevated anxiety and increased susceptibility to depression .

This behavioral phenotype was associated with a reduction in the levels of SIRT1 in the brain and in peripheral blood mononuclear cells, with peripheral blood mRNA expression of SIRT1 predicting the extent of behavioral despair only when depression-like behavior was induced by juvenile stress . Studies have linked SIRT1 to depression mechanisms⁵⁵ Studies have linked SIRT1 to depression mechanisms
Lu G et al. Role and Possible Mechanisms of Sirt1 in Depression. Oxid Med Cell Longev. 2018 through regulation of neuroinflammation, neurogenesis, and circadian control.

Practical Implications

SIRT1 is activated by NAD+ availability⁶⁶ NAD+ availability
NAD+ levels decline with age and can be supported through diet and supplementation, calorie restriction, exercise, and compounds like resveratrol (found in red wine and grapes).

Optimal SIRT1 activation is the most crucial step in the neuroprotection provided by resveratrol against cognitive impairment . For G allele carriers, whose SIRT1 regulation may be altered, supporting NAD+ metabolism through lifestyle becomes particularly relevant.

The variant's association with both metabolic conditions (obesity, dyslipidemia) and neurological/psychiatric conditions (MS, depression, AMD) reflects SIRT1's pleiotropic role in cellular stress response. The complex age-dependent and tissue-specific effects mean that G carriers may benefit from supporting SIRT1 function through multiple pathways⁷⁷ supporting SIRT1 function through multiple pathways
including NAD+ precursors, calorie restriction mimetics, and antioxidant support rather than relying on a single intervention.

Interactions

rs7895833 does not act in isolation within the SIRT1 gene.

The rs3818292-rs3758391-rs7895833 haplotype G-T-G was associated with increased odds of exudative AMD . Other SIRT1 variants including rs3818292 (intronic), rs3758391 (promoter), and rs7069102 (intron 4) have been studied in combination with rs7895833, showing that multiple regulatory variants within SIRT1 interact to modulate protein expression and disease risk. These compound effects are particularly pronounced in aging-related conditions where SIRT1's protective functions become critical.